Other Ophthalmic Surgery Organ Transplantation Orthopaedics Other Osteoarthritis Osteoporosis Otitis Otorhino. Dr. Margaret Tempero, now Deputy Director of the University of California at San Francisco Comprehensive Cancer Center, conducted the study. Ten of the patients had metastatic rectal cancer and 35 patients had metastatic colon cancer. Survival data was analyzed for all 45 colorectal patients and the median survival from the time of commencing Theratope vaccine was 14.2 months and 31.0 months from the time of diagnosis of metastasis. In the subgroup of 27 patients with metastatic colon cancer who had previously received first-line chemotherapy treatment for metastasis, the median survival was 12.5 months from time of commencing vaccine.
Colorectal cancer is one of the leading causes of cancer death worldwide.
Theratope vaccine is designed to stimulate the body's immune system to mount a response against cancerous cells. The vaccine is generally well tolerated and may be evaluated for use in conjunction with other cancer therapies. Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.